Hologic Stockholders Sue Over Merger Proxy Statement

Reuters
Jan 27
Hologic Stockholders Sue Over Merger Proxy Statement

Hologic, Inc. has entered into a merger agreement with Hopper Parent Inc. and Hopper Merger Sub Inc., under which Hopper Merger Sub will merge with and into Hologic. Following the completion of the transaction, Hologic will become a wholly owned subsidiary of Hopper Parent Inc. In connection with the proposed merger, Hologic has filed both a preliminary and definitive proxy statement with the SEC and has begun mailing the definitive proxy statement to its stockholders. The company has also disclosed that several lawsuits have been filed by purported stockholders relating to the merger, but stated that it believes the allegations are without merit. To avoid potential delays or adverse effects on the merger and to minimize litigation risks and costs, Hologic is supplementing its proxy statement with additional disclosures.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hologic Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-022672), on January 26, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10